PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents

Enrolling by invitation

Conditions studied: Vitiligo

In brief

The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.

Key facts

Study ID

NCT07659418

Run by

CorEvitas

People needed

2500

Starts

2026-06-01

Expected to finish

2099-12-31

Last updated by the study team

2026-06-22

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Individuals are eligible for enrollment if they meet all of the following criteria:
• Have a dermatologist- or qualified dermatology practitioner-confirmed diagnosis of nonsegmental vitiligo (NSV).
• Is at least 12 years of age or older at the time of enrollment.
• Is willing and able to provide informed consent or assent, with parent/legal guardian consent as applicable.
• Adult participants are willing and able to provide required personal information
• Full legal name, sex, date of birth, and home ZIP/postal code
• Meet the criteria for one of the following enrollment cohorts at the time of enrollment:
• Cohort 1: Eligible Medication Initiators - Individuals initiating a prescribed eligible NSV medication at the time of enrollment.
• Cohort 2: Not Initiating Eligible Medication - Individuals not currently receiving NSV medication at the time of enrollment, Individuals receiving eligible NSV medication prior to enrollment.

You may not qualify if…

• An individual who meets any of the following criteria will be excluded from participation in the registry:
• Is participating or planning to participate in a blinded clinical trial for a vitiligo therapy.

Where it is running

• CorEvitas, LLC — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.